Arthritis & Rheumatism

Anifrolumab shows long-term promise in patients with lupus

Type I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the ...

Diseases, Conditions, Syndromes

Coronavirus and asthma: what we know so far

When the new coronavirus arrived in early 2020, people with asthma were identified as being at higher risk from the disease. Judgements about who was at increased risk had to be made on the best available evidence—which ...

Diseases, Conditions, Syndromes

Old bones vulnerable to long-term use of oral corticosteroids

A review of data by University of South Australia researchers has found many older people taking oral corticosteroids long-term are not having the recommended bone density tests or fracture prevention therapy, leaving them ...

Immunology

New model IDs inflammatory asthma without sputum

(HealthDay)—A new prediction model identifies eosinophilic asthma without the need for sputum induction, according to a study published online Dec. 28 in Allergy.

page 1 from 3